| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Meetings and Conferences |
|
|
| |
| |
| |
November 18, 2015 |
|
|
| |
|
|
| |
|
|
|
Abcam Events, Online Event
2016-01-21
Our understanding of and therapeutic strategy for treating neoplastic diseases has improved through decades of research. Only recently has a novel class of conserved gene regulatory molecules, termed microRNAs (miRNAs), been identified as a major contributor to malignant neoplastic disease.
This webinar will review:
|
|
|
|
|
|
|
|
Organized by:
|
|
Abcam |
|
|
Invited Speakers:
|
|
Dr Brian D. Adams Brian D. Adams, PhD is currently an Instructor at Harvard Medical School in the lab of Dr Frank Slack working to elucidate the role of microRNAs (miRNAs) in TNBC, to develop miR-34a as a therapeutic agent, and to establish a miRNA biomarker profile that associates with overall outcome and drug response in TNBC patients. Brian has over 9 years of experience in the fields of microRNA and cancer research.
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
N/A
|
|
|
|
|
|
|
|
Registration:
|
|
Register Today to hear Dr Brian D. Adams discuss this exciting topic in further detail and answer your questions during a live Q&A session! http://bit.ly/mirnabiomarkerwebinar
|
|
|
E-mail:
|
|
events@abcam.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|